Notable Labs, Ltd. (NTBLQ)
OTCMKTS · Delayed Price · Currency is USD
0.160
+0.010 (6.67%)
Oct 30, 2024, 4:00 PM EDT

Notable Labs Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Revenue
0.310.310.010.29
Revenue Growth (YoY)
3812.50%3775.00%-97.19%-
Cost of Revenue
0.20.2--
Gross Profit
0.120.110.010.29
Selling, General & Admin
9.5310.065.165.73
Research & Development
5.964.717.7811.47
Operating Expenses
15.4914.7712.9317.2
Operating Income
-15.37-14.66-12.92-16.91
Other Non Operating Income (Expenses)
4.833.39-2.520.86
EBT Excluding Unusual Items
-10.54-11.26-15.45-16.05
Other Unusual Items
--1.04-
Pretax Income
-10.54-11.26-14.41-16.05
Net Income
-10.54-11.26-14.41-16.05
Net Income to Common
-10.54-11.26-14.41-16.05
Shares Outstanding (Basic)
7316
Shares Outstanding (Diluted)
7316
Shares Change (YoY)
-51.81%403.74%-88.40%-
EPS (Basic)
-1.42-3.41-21.97-2.84
EPS (Diluted)
-1.42-3.41-21.97-2.84
Free Cash Flow
-15.2-13.78-11.68-15.49
Free Cash Flow Per Share
-2.04-4.17-17.82-2.74
Gross Margin
37.06%36.45%100.00%100.00%
Operating Margin
-4910.54%-4728.06%-161550.00%-5934.74%
Profit Margin
-3368.05%-3633.55%-180087.50%-5632.28%
Free Cash Flow Margin
-4857.19%-4445.48%-146037.50%-5436.49%
EBITDA
-15.12-14.4-12.6-16.59
D&A For EBITDA
0.250.260.320.33
EBIT
-15.37-14.66-12.92-16.91
Source: S&P Capital IQ. Standard template. Financial Sources.